Harel Insurance Investments & Financial Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
NW
AM
Harel Insurance Investments & Financial Services's NVS Position: Q2 2026 in Review
Harel Insurance Investments & Financial Services increased its Novartis (NVS) stake by 29% in Q2 2026, buying an estimated $388K and bringing the position to 11,662 shares worth $1.83M. The position accounts for 0.01% of the portfolio, ranked #176.
Harel Insurance Investments & Financial Services first reported a position in NVS in Q4 2015 and has held it in 20 quarters since. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Harel Insurance Investments & Financial Services held 11,662 shares of Novartis worth $1.83M as of Q2 2026.
- Harel Insurance Investments & Financial Services bought 2,588 Novartis shares in Q2 2026, an estimated $388K.
- Novartis made up 0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #176 holding.
- Harel Insurance Investments & Financial Services first reported a position in Novartis in Q4 2015 and has held it in 20 quarters since.
- 1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.